Skip to main content
. 2013 Sep 15;24(18):2849–2860. doi: 10.1091/mbc.E13-06-0298

FIGURE 5:

FIGURE 5:

JAM-A regulates Rap2 activity and localization to tight junctions. (A) Rap2 colocalizes with JAM-A (JA) in IECs and (B) in colonic mucosa from human pathology specimens. (A, B) Cells and tissues were pretreated with 0.1% Triton X-100 before fixation. (C) Simultaneous down-regulation of JAM-A (JA) and Rap2c (R2c) in SK-CO15 cells has no additive effect on TER compared to isolated down-regulation of JAM-A (JA) or Rap2c (R2c; n = 3; mean relative resistance with 95% confidence interval). (D) JAM-A (JA)–deficient IECs from two independent JAM-A targets display decreased Rap2 activity compared to control cells (NS), as assessed by Ral-GDS pull down (densitometry calculated as Rap2 pull-down signal over total Rap2 signal, relative to NS control). (E) IECs transiently deficient in afadin (AF) have decreased levels of Rap2 activity compared to control cells (Scr; densitometry calculated as Rap2 pull-down signal over total Rap2 signal, relative to Scr control). (F) Rap2 coimmunoprecipitates with afadin from cell lysates solubilized with a Brij97-based buffer. (G) Incubation of confluent SK-CO15 monolayers with σ1 or σ1_G381A (10 μg/ml) for 1 h leads to decreased Rap2c localization at tight junctions.